Adam Bruce

Adam Bruce is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as the Chief Executive Officer and Chairman of Abarceo Pharma since July 2020. Adam is also the Founder and Board Member of TikoMed AB, where Adam has held multiple leadership roles since March 2002, including CEO and Working Chairman. Additionally, Adam has been the Owner of WaveSeven AB since 2014. Adam's educational background includes studies at Lund University and specialized training at Styrelse Akademin and the Executive Foundation Lund.